The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Dispatch and carefully placed it inside my copy of And The Band Played On: Politics, People, and the AIDS Epidemic – his most ...
Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...
The European Court of Human rights (ECHR) ruled Thursday that Italy did not violate the rights of a man with HIV (which had possibly developed into AIDS) by keeping him in a general prison and ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback